Schonfeld Strategic Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $249K | Sell |
507
-750
| -60% | -$407K | ﹤0.01% | 1657 |
|
|
2025
Q4 | $728K | Sell |
1,257
-20,101
| -94% | -$11.4M | ﹤0.01% | 1250 |
|
|
2025
Q3 | $10.4M | Sell |
21,358
-5,112
| -19% | -$2.38M | 0.06% | 342 |
|
|
2025
Q2 | $10.7M | Buy |
+26,470
| New | +$11.1M | 0.07% | 319 |
|
|
2025
Q1 | – | Sell |
-31,192
| Closed | -$16.2M | – | 2494 |
|
|
2024
Q4 | $16.2M | Buy |
31,192
+30,826
| +8,422% | +$16.9M | 0.09% | 186 |
|
|
2024
Q3 | $226K | Sell |
366
-1,138
| -76% | -$674K | ﹤0.01% | 1774 |
|
|
2024
Q2 | $832K | Sell |
1,504
-6,638
| -82% | -$3.8M | 0.01% | 1285 |
|
|
2024
Q1 | $4.73M | Sell |
8,142
-25,701
| -76% | -$14.4M | 0.03% | 672 |
|
|
2023
Q4 | $18M | Buy |
33,843
+21,736
| +180% | +$10.5M | 0.12% | 184 |
|
|
2023
Q3 | $6.13M | Buy |
12,107
+4,260
| +54% | +$2.27M | 0.05% | 485 |
|
|
2023
Q2 | $4.09M | Buy |
+7,847
| New | +$4.23M | 0.04% | 543 |
|
|
2023
Q1 | – | Sell |
-4,100
| Closed | -$2.26M | – | 2650 |
|
|
2022
Q4 | $2.26M | Sell |
4,100
-6,656
| -62% | -$3.53M | 0.02% | 775 |
|
|
2022
Q3 | $5.46M | Sell |
10,756
-730
| -6% | -$409K | 0.05% | 503 |
|
|
2022
Q2 | $6.24M | Sell |
11,486
-5,940
| -34% | -$3.27M | 0.06% | 404 |
|
|
2022
Q1 | $10.3M | Buy |
17,426
+5,880
| +51% | +$3.38M | 0.09% | 263 |
|
|
2021
Q4 | $7.7M | Buy |
11,546
+5,811
| +101% | +$3.63M | 0.07% | 346 |
|
|
2021
Q3 | $3.28M | Buy |
+5,735
| New | +$3.15M | 0.03% | 551 |
|
|
2021
Q2 | – | Sell |
-16,211
| Closed | -$7.4M | – | 2310 |
|
|
2021
Q1 | $7.4M | Sell |
16,211
-48,240
| -75% | -$23M | 0.09% | 308 |
|
|
2020
Q4 | $30M | Buy |
64,451
+62,151
| +2,702% | +$29.1M | 0.4% | 36 |
|
|
2020
Q3 | $1.01M | Sell |
2,300
-3,438
| -60% | -$1.42M | 0.02% | 701 |
|
|
2020
Q2 | $2.08M | Sell |
5,738
-6,611
| -54% | -$2.22M | 0.05% | 395 |
|
|
2020
Q1 | $3.5M | Buy |
12,349
+10,849
| +723% | +$3.42M | 0.22% | 99 |
|
|
2019
Q4 | $487K | Sell |
1,500
-318
| -17% | -$96.4K | 0.01% | 756 |
|
|
2019
Q3 | $530K | Sell |
1,818
-41,444
| -96% | -$11.9M | 0.02% | 635 |
|
|
2019
Q2 | $12.7M | Sell |
43,262
-8,938
| -17% | -$2.46M | 0.45% | 53 |
|
|
2019
Q1 | $14.3M | Buy |
52,200
+27,385
| +110% | +$6.82M | 0.5% | 41 |
|
|
2018
Q4 | $5.55M | Buy |
24,815
+20,415
| +464% | +$4.79M | 0.21% | 129 |
|
|
2018
Q3 | $1.07M | Buy |
4,400
+3,305
| +302% | +$760K | 0.05% | 419 |
|
|
2018
Q2 | $227K | Buy |
+1,095
| New | +$232K | 0.01% | 678 |
|
|
2017
Q4 | – | Sell |
-1,774
| Closed | -$336K | – | 880 |
|
|
2017
Q3 | $336K | Sell |
1,774
-26,036
| -94% | -$4.72M | 0.03% | 435 |
|
|
2017
Q2 | $4.85M | Buy |
+27,810
| New | +$4.67M | 0.5% | 41 |
|
Other funds holding TMO
VCM
Schonfeld Strategic Advisors's TMO Position: Q1 2026 in Review
Schonfeld Strategic Advisors reduced its Thermo Fisher Scientific (TMO) stake by 60% in Q1 2026, selling an estimated $407K and leaving 507 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1657.
Schonfeld Strategic Advisors first reported a position in TMO in Q2 2017 and has held it in 31 quarters since. The position peaked at $30M in Q4 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Schonfeld Strategic Advisors held 507 shares of Thermo Fisher Scientific worth $249K as of Q1 2026.
- Schonfeld Strategic Advisors sold 750 Thermo Fisher Scientific shares in Q1 2026, an estimated $407K.
- Thermo Fisher Scientific made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1657 holding.
- Schonfeld Strategic Advisors first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 31 quarters since.
- Schonfeld Strategic Advisors's Thermo Fisher Scientific position peaked at $30M in Q4 2020.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.